Obiltoxaximab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
A new agent used to treat and prevent inhalational anthrax has received FDA approval.
Obiltoxaximab, marketed as Anthim, is…